Indeed, AKT2 is amplified and overexpressed in pancreatic carcinomas and AKT2 antisense RNA can greatly diminish the tumorigenic phenotype of pancreatic cancer cells harboring amplified AKT2 [44]. This evidence concerns the gene AKT2 and pancreatic neoplasm.